Can the NHS Prescribe Wegovy — and What Does That Mean for You?

What NICE actually says about NHS Wegovy prescribing

The NICE guidance that underpins NHS access to Wegovy (TA875, published in March 2023) sets several conditions that must all be satisfied simultaneously. Adults must have a BMI of 35 or above (with thresholds typically 2.5 kg/m² lower for South Asian, Chinese, Middle Eastern, Black African or African-Caribbean backgrounds). They must have at least one weight-related comorbidity such as type 2 diabetes, high blood pressure or obstructive sleep apnoea. And they must receive the medicine as part of a specialist weight management service that includes multidisciplinary support (diet guidance, physical activity support, and behavioural input) not a standalone prescription.

The two-year cap is also firm within the NHS framework: if less than 5% weight loss has been achieved after six months on the maintenance dose, NICE recommends stopping. These rules govern does the NHS prescribe Wegovy in practice, not just in principle. The guidance is real; the pathway is narrow.

Scotland, Wales and Northern Ireland operate their own frameworks, and thresholds can differ. If you're based in Northern Ireland specifically, access criteria there have their own nuances worth reading before you assume the England TA875 criteria apply.

Why does Wegovy require a specialist service rather than a GP?

This is the question our prescribers field regularly, because most people's first instinct is to ask their GP. The NICE recommendation for Wegovy was deliberately tied to specialist services because the evidence underpinning it (the STEP 1 trial published in the New England Journal of Medicine, which showed around 15% average weight reduction over 68 weeks) was generated in a structured clinical setting alongside diet and activity support, not in isolation.

In practice, this means a GP cannot simply generate an NHS Wegovy prescription at a routine appointment. They would need to refer you into a tier 3 or tier 4 specialist weight management programme, and those services have their own waiting lists, in many parts of England, waits of a year or more are not unusual. If you want to understand whether a GP can prescribe Wegovy and under what circumstances, that page covers the current rules in detail, and whether GPs can prescribe Wegovy on the NHS more broadly is explored in full there too. From April 2026, GP practices can prescribe tirzepatide (Mounjaro) under the new GP contract for weight management, but Wegovy remains on the specialist-service pathway for NHS purposes.

Does the NHS prescribe Wegovy everywhere in England, or does it vary?

Access varies considerably by integrated care board area. NHS England has published guidance on weight management injections setting out how services should be commissioned, but commissioning is a local decision, and not every area has fully functional tier 3 services with short waits. Some ICBs have paused referrals while capacity catches up with demand. Meeting the NICE criteria on paper does not guarantee a quick start to treatment.

For people who meet the licensed eligibility criteria for Wegovy (broadly, a BMI of 30 or above, or 27 or above with a weight-related condition) but cannot access NHS services quickly, a private prescription from a regulated pharmacy is a legal and clinically supervised alternative. It is worth comparing what a private Wegovy prescription actually involves before making a decision either way. The cost picture matters too, and the full Wegovy overview covers both the clinical and access angles.

Private prescribing: the regulated alternative

A private prescription follows the same legal framework as an NHS one, Wegovy is a prescription-only medicine under UK law, and any legitimate supply requires a clinician to assess you and decide you are suitable. The difference is that a private prescriber is not bound by the specialist-service requirement or the two-year NHS cap. Eligibility criteria follow the licensed indications in the medicine's SmPC rather than NICE's commissioning constraints.

At nume, a GPhC-registered Independent Prescriber personally reviews every consultation, the same day, without the waiting list. If you want to understand the process before you commit to anything, how Wegovy prescribing works in practice sets out each step clearly. And if you'd like to see who oversees the clinical side of things at our pharmacy, our lead prescriber's profile is there to read. You can also verify our GPhC registration at any time on the GPhC pharmacy register, registration number 9012878.

If you want to explore whether treatment through a regulated private pharmacy fits your situation, start your free consultation and a prescriber will review your answers the same day.